-
Cantor Fitzgerald Reaffirms Overweight Rating for ARS Pharmaceuticals (NASDAQ:SPRY)
Source: Buzz FX / 08 Oct 2024 12:21:10 America/New_York
Cantor Fitzgerald Reaffirms Overweight Rating for ARS Pharmaceuticals (NASDAQ:SPRY) Written by MarketBeat October 8, 2024 Share Link copied to clipboard. ARS Pharmaceuticals ( NASDAQ:SPRY - Get Free Report ) 's stock had its "overweight" ra
Read more...